Infertility. Female infertility associated with anovulation,Female infertility of tubal origin,Female infertility of other origin,Female infertility, unspecified,
Conditions
Interventions
Intervention 1: Performing hysteroscopy in the 5-7 days of the IVF cycle treatment and uterine irrigation with normal saline in the patients in intervention group . For patients in the control group d
Treatment - Other
Treatment - Drugs
Performing hysteroscopy in the 5-7 days of the IVF cycle treatment and uterine irrigation with normal saline in the patients in intervention group . For patients in the control group did not add any i
In the control group the traditional IVF cycle will be done without any additional intervention
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:regular mense;age less than 40;BMI=19-30;without any prior hysteroscopy examination or previous IVF or ICSI; with a normal Transvaginal sonography (TVS) (in the day 2-3 same cycle);normal hystrosalpingo graphy (HSG) (between 6to24 mounths) . Exclusion criteria : recurrent miscamiage (3 or more miscarriage); inter menstrual bleeding; any doubt about uterine cavity abnormality; server male factor request to PESA or TESE; patients with poly cystic ovary syndrome or endometriosis ;hydrosalpinx ;ovarian cyst ; cancellation of the same cycle for any reason
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical pregnancy rate in two groups. Timepoint: 4 weeks after embryo transfer transvaginal sonography will be done and gestatinal sac will be evaluated. Method of measurement: Find gestational sac on transvaginal sonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Chemical pregnancy rate in two group ,abortion , implantation rate in two groups. Timepoint: two weeks after transfer for biochemical pregnancy,4weeks for clinical pregnancy,12 weeks after transfer for abortion,two weeks after transfer for implantation rate. Method of measurement: BHCG for biochemical ,trans vaginal sonography for clinical,physical examination and trans vaginal sonography for abortion ,trans vaginal sonography for implantation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMarzieh Ghasemi
Tehran University of Medical Sciences,infertility ward
Outcome results
None listed